Last reviewed · How we verify
Dexpanthenol foam spray, old formulation
Dexpanthenol foam spray, old formulation is a Small molecule drug developed by Bayer. It is currently in Phase 2 development.
At a glance
| Generic name | Dexpanthenol foam spray, old formulation |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Moisturizing Effect of Two Dexpanthenol Formulations (PHASE2)
- Efficacy of Dexpanthenol in Thermic Erythema (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexpanthenol foam spray, old formulation CI brief — competitive landscape report
- Dexpanthenol foam spray, old formulation updates RSS · CI watch RSS
- Bayer portfolio CI
Frequently asked questions about Dexpanthenol foam spray, old formulation
What is Dexpanthenol foam spray, old formulation?
Dexpanthenol foam spray, old formulation is a Small molecule drug developed by Bayer.
Who makes Dexpanthenol foam spray, old formulation?
Dexpanthenol foam spray, old formulation is developed by Bayer (see full Bayer pipeline at /company/bayer).
What development phase is Dexpanthenol foam spray, old formulation in?
Dexpanthenol foam spray, old formulation is in Phase 2.